| Name |
Vatinid 0,5 mg tablete |
| Marketing Authorisation Number |
HR-H-606692237 |
| Active Substance |
repaglinid |
| Composition |
svaka tableta sadrži 0,5 mg repaglinida |
| Pharmaceutical Form |
Tableta |
| Manufacturer |
Laboratori Fundacio Dau, Barcelona, Španjolska |
| Marketing Authorisation Holder |
Novatin Limited, 230, Second Floor, Eucharistic Congress Road, Mosta, Malta |
| Marketing Authorisation Date |
02.10.2025 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/25-02/67 |
| Registration Number |
381-12-01/70-25-05 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
A10BX02 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
